NEW YORK (GenomeWeb) – Enzo Biochem announced after the close of the market on Thursday that its third quarter earnings rose 2 percent year over year, thanks largely to an 8 percent increase in revenues from its clinical lab business.

For the three months ended April 30, the company reported revenues of $27.1 million, up from $26.4 million in Q3 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.